Table 1.
Study | Included? | Figure chosen | Relevant meta-analysis | Comment |
---|---|---|---|---|
Herranz-Martin et al. [111] | Yes | Fig. S2D | Cerebellar neuronal loss | Purkinje cell counts between HRE-10 (disease control) and HRE-102 |
Tan et al. [93] | Yes | Table 3 | Cerebellar neuronal loss | Spino- and Cerebro-cerebellum were averaged for Purkinje cells — other studies did not state a specific area of the cerebellum; therefore, both were included to avoid bias |
Hao et al. [56] | Yes | Figure 5D | Cerebellar neuronal loss; DPR-related neuronal loss | Purkinje counts across an age range (averaged over time) comparing poly-PR with controls. Figure 5D — molecular layer thickness was not chosen as it is not directly neuronal counts (i.e. neuronal density could be increased in a smaller area) |
Zhang et al. [69] | Yes | Fig. S3G | Cerebellar neuronal loss; DPR-related neuronal loss | Purkinje cell counts between GFP and poly-PR. Time points were averaged |
May et al. [22] | Yes | Figure 3B | Dendritic arborisations | Number of dendritic crossings. All distances from the soma of dendritic crossings were averaged to give a total effect across the neuron |
Park et al. [24] | Yes | Figure 1B | Dendritic arborisations | Number of dendritic branch points under different DPR transgenes (DPR effect was averaged) |
Schweizer Burguete et al. [23] | Yes | Fig. S4B | Dendritic arborisations | Shows late control versus late experimental of dendritic crossings. Preferred to Fig. 3H due to similarity to May 2014 |
Perry et al. [44] | Yes | Figure 2J | Dendritic arborisations | Percentage retractions of synapses at the NMJ. Means were not multiplied by − 1 as, unlike other studies, a positive increase was reflective of a negative effect |
O’Rourke et al. [99] | Yes | Figure 3G | Dendritic arborisations; NMJ abnormalities | Percentage of fragmented NMJs. Means were not multiplied by − 1 as, unlike other studies, a positive increase was reflective of a negative effect |
LaClair et al. [80] | Yes | Figure 2E/F | DPR-related neuronal loss | Figure 2E (GA) and F (PR) were averaged to give an overall DPR effect on hippocampal neuron density as well as to avoid bias regarding which DPR was the most important |
Darling et al. [77] | Yes | Figure 1A | DPR-related neuronal loss | All DPRs were averaged to compare against the control. Cell viability of iPSCs was assessed |
Zhang et al. [65] | Yes | Figure 1G | DPR-related neuronal loss | Score of hippocampal neuronal loss — time points were averaged |
Xu and Xu [21] | Yes | Figure 5E | NMJ abnormalities | Total bouton counts |
Perry et al. [44] | Yes | Figure 1D | NMJ abnormalities | Total bouton counts. (G4C2)8 was averaged as a control, whilst (G4C2)58 and GR36/100 were averaged as experimental |
Freibaum et al. [42] | Yes | Figure 1F | NMJ abnormalities | Total bouton counts — control and (G4C2)8 were averaged as this is to represent disease control |
Herranz-Martin et al. [111] | Yes | Figure 3B | NMJ abnormalities | Percentage of pathological NMJs — not included for dendrites as pathological is ambiguous. HRE-10 was averaged with control. Means were not multiplied by − 1 as, unlike other studies, a positive increase was reflective of a negative effect |
Frick et al. [16] | Yes | Figure 6B | Reduced C9orf72 | Normalised C9orf72 levels in the cerebellum |
Saberi et al. [96] | Yes | Figure 5N | Reduced C9orf72 | Normalised C9orf72 levels in the frontal cortex (chosen over occipital cortex) |
Belzil et al. [103] | Yes | Figure 1B | Reduced C9orf72 | Normalised C9orf72 levels in the frontal cortex (chosen over CB due to frontal cortex being more widely studied) |
Waite et al. [92] | Yes | Figure 3B | Reduced C9orf72 | Normalised C9orf72 levels in the frontal cortex (C9-ALL was chosen over specific variants) |
Yang et al. [76] | No | Figure 2B | Dendritic arborisations | Not included as only the number of neurons counted were given, not the number of animals per genotype (such as other studies) which would skew the weighting |
Park et al. [24] | No | Figure 1C | Neurite length | Dendritic length — N not high enough for meta-analysis of neurite length |
Zhang et al. [28] | No | Fig. S5B | Neurite length | No sample sizes were given — unable to calculate confidence intervals |
Swaminathan et al. [73] | No | Figure 5B | Neurite length | Neurite length meta-analysis N was too small |
Studies that are italicised had their means multiplied by − 1 as these studies measured negative effects but as a percentage (an increase in percentage is a negative outcome) and therefore were brought in line with the other studies. Abbreviations: HRE, hexanucleotide repeat expansion; GFP, green fluorescent protein; DPR, dipeptide repeat protein; NMJ, neuromuscular junction; iPSCs, induced pluripotent stem cells